Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexiletine for Giant T-wave Electrical Alternans and Ventricular Arrhythmias
NCT05619120Recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2023
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of mexiletine in ventricular tachycardia (VT) and ventricular fibrillation (VF) (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Change in the occurrence of macroscopic TWA at 7 days. Started Jan 2023; status: recruiting.
02
Drugs
mexiletine
03
Conditions
ventricular tachycardia (VT)ventricular fibrillation (VF)
Beyond the preview
Go deeper on NCT05619120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05619120.